# Malaria in Early Life Study

> **NCT02001428** · NA · COMPLETED · sponsor: **Gadjah Mada University** · enrollment: 757 (actual)

## Conditions studied

- Plasmodium Falciparum Malaria
- Plasmodium Vivax Malaria

## Interventions

- **DRUG:** dihydroartemisinin-piperaquine

## Key facts

- **NCT ID:** NCT02001428
- **Lead sponsor:** Gadjah Mada University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-21
- **Primary completion:** 2016-03-31
- **Final completion:** 2017-05-17
- **Target enrollment:** 757 (ACTUAL)
- **Last updated:** 2018-08-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02001428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02001428, "Malaria in Early Life Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02001428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*